U.S. markets close in 6 hours 25 minutes

Rapid Micro Biosystems, Inc. (RPID)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.90+0.90 (+5.00%)
As of 9:33AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close18.00
Open18.00
Bid7.41 x 800
Ask0.00 x 800
Day's Range18.00 - 18.90
52 Week Range17.12 - 27.04
Volume421
Avg. Volume293,685
Market Cap776.45M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.00
Earnings DateAug 26, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rapid Micro Biosystems, Inc.
    Analyst Report: Thermo Fisher Scientific Inc.Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
  • GlobeNewswire

    Rapid Micro Biosystems Set to Join Russell 2000®, Russell 3000® and Russell Microcap® Indexes

    LOWELL, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it is set to join the Russell 2000®, Russell 3000® and Russell Microcap® indexes, effective after the U.S. market opens on September 20, 2021, according to a preliminary list of quarterly IPO addition

  • GlobeNewswire

    Rapid Micro Biosystems to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

    LOWELL, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15th, 2021. Rob Spignesi, President and CEO, and Sean Wirtjes, CFO, are s

  • GlobeNewswire

    Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 Outlook

    Reports second quarter 2021 commercial revenue of $5.7 million, representing 135% year-over-year growth Issues full-year 2021 outlook for commercial revenue of at least $24.0 million, representing at least 70% year-over-year growth LOWELL, Mass, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release